Skip to main content
. Author manuscript; available in PMC: 2013 Nov 13.
Published in final edited form as: Eur J Cancer. 2012 Aug 23;48(18):10.1016/j.ejca.2012.06.027. doi: 10.1016/j.ejca.2012.06.027

Table 4.

Time course of% apoptosis from baseline for the four CLL patients treated with SF1126.

Time points (h) Patient 1 Patient 2 Patient 3 Patient 4
1-h Post-dose 13 −3 52 8
4-h Post-dose 38 38 214 54
6-h Post-dose 6 17 38 **
24-h Post dose 44 ** 100 35
72-h Post-dose 56 48 −5 −4
1-week Post-dose 44 24 ** 15